☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
P-II Randomized Trial
Artios Initiates P-II Randomized Trial of ART0380 + Gemcitabine for Platinum Resistant Ovarian Cancer
February 10, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.